| ACE-I | Angiotensin-Converting Enzyme Inhibitor |
| AL | Light-Chain Amyloidosis |
| AMY-CCM | Amyloidosis–Cardiac Contractility Modulation Registry |
| ARB | Angiotensin Receptor Blocker |
| ARNI | Angiotensin Receptor–Neprilysin Inhibitor |
| ATTR | Transthyretin |
| ATTR-CM | Transthyretin Cardiac Amyloidosis |
| BB | Beta-Blocker |
| BMI | Body Mass Index |
| CABG | Coronary Artery Bypass Grafting |
| CaMKII | Calcium/Calmodulin-Dependent Protein Kinase II |
| CCB | Calcium Channel Blocker |
| CCM | Cardiac Contractility Modulation |
| CMR | Cardiac Magnetic Resonance |
| CRT | Cardiac Resynchronization Therapy |
| ECG | Electrocardiogram |
| EDV | End-Diastolic Volume |
| EF | Ejection Fraction |
| eGFR | Estimated Glomerular Filtration Rate |
| ESV | End-Systolic Volume |
| H | Hereditary |
| HF | Heart Failure |
| HSP70 | Heat Shock Protein 70 |
| ICD | Implantable Cardioverter-Defibrillator |
| IQR | Interquartile Range |
| KCCQ | Kansas City Cardiomyopathy Questionnaire |
| MAPK | Mitogen-Activated Protein Kinase |
| MRA | Mineralocorticoid Receptor Antagonist |
| NT-proBNP | N-terminal pro-B-type Natriuretic Peptide |
| NYHA | New York Heart Association (Functional Class) |
| OMT | Optimal Medical Therapy |
| PCI | Percutaneous Coronary Intervention |
| PKA | Protein Kinase A |
| PKB | Protein Kinase B |
| PLB | Phospholamban |
| ROS | Reactive Oxygen Species |
| RyR2 | Ryanodine Receptor 2 |
| SERCA | Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase |
| SGLT2-i | Sodium-Glucose Cotransporter-2 Inhibitor |
| TAPSE | Tricuspid Annular Plane Systolic Excursion |
| TTR | Transthyretin Protein |
| WHF | Worsening Heart Failure |
| WT | Wild-Type |
| α-MHC | Alpha-Myosin Heavy Chain |